Omega-3 (EPA+DHA) Index; Omega-6/Omega-3 Ratio; Arachidonic Acid/EPA Ratio; Arachidonic Acid; EPA; DHA
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)
1. Baseline and monitoring of individuals with known CVD (acute and chronic) to determine Rx and compliance. 2. Identify patients with known CVD risk with low omega-3 levels who may be candidates for supplementation/therapy. 3. Monitor patients on omega-3 supplementation/therapy to determine efficacy of treatment. 4. Potential role in risk reduction for non-CVD outcomes-aged related macular degeneration, RA, cancer, etc. (early data).
Omega-3 and -6 Fatty Acids, Cardio IQ®